Email Updates

You are here

MTN 003B

Status
Completed
Phase
IIb
Principal Investigator(s)
Sharon A. Riddler, MD, MPH
Objective
The purpose of this study is to determine if taking daily TDF and FTC/TDF as a part of the study MTN-003 has an effect on bone mineral density (BMD).
 
Results: TDF-containing oral PrEP resulted in small but significant reversible decreases in hip and spine BMD among young African women.
Prevention Option(s)
Microbicides
Observational
Prospective Cohort
Arms and Assigned Interventions
Description
Daily dosing
Mode of Delivery
Tablet
Products
TDF/FTC (Truvada)
ARMs
Experimental
Description
Daily dosing
Mode of Delivery
Tablet
ARMs
Placebo Comparator
Trial Sponsors
NIAID, MTN
November 2009
May 2013
Enrollment
518
18
Years
45
Years
Population
Women
Sites

Seke South Clinical Research Site

Harare
Zimbabwe

Spilhaus Clinical Research Site

Harare
Zimbabwe

Zengeza 3 Clinic

Harare
Zimbabwe

MUJHU CARE LTD CRS

Kampala
Uganda